Hypoxia and angiogenesis in primary clear cell renal carcinoma and its effect on patient prognosis

Hypoxia and angiogenesis in primary clear cell renal carcinoma and its effect on patient prognosis

Dades bibliogràfiques
Autors principals:	Charlesworth, P, Turner, G, Crew, J, Cranston, D, Protheroe, A, Harris, A
Format:	Conference item
Publicat:	2008

Ítems similars

Changing prognosis of renal cell carcinoma: A single-centre experience over 25 years
per: Charlesworth, P, et al.
Publicat: (2013)

24 YEARS OF RENAL CELL CARCINOMA NEPHRECTOMIES IN OXFORD, UK (1983-2007)
per: Charlesworth, P, et al.
Publicat: (2009)

CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC.
per: Biswas, S, et al.
Publicat: (2012)

Human chorionic gonadotropin-secreting clear cell renal cell carcinoma with paraneoplastic gynaecomastia.
per: Mohammed Ilyas, M, et al.
Publicat: (2008)

The role of hypoxia-inducible MIR-210 in the biology and prognosis of clear cell kidney cancer
per: McCormick, I, et al.
Publicat: (2011)

The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.
per: Nikitenko, L, et al.
Publicat: (2013)

Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.
per: Turner, K, et al.
Publicat: (2002)

Comprehensive molecular characterization of clear cell renal cell carcinoma
per: Getz, Gad Asher, et al.
Publicat: (2018)

Primary Hepatocellular carcinoma: management and prognosis
per: Murtaza Mustafa, et al.
Publicat: (2016)

Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
per: Culliford, R, et al.
Publicat: (2024)

The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma.
per: Yuen, J, et al.
Publicat: (2007)

Metastatic clear cell renal cell carcinoma presenting as multiple colonic polyps.
per: Chetty, R, et al.
Publicat: (2011)

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
per: Sivridis, E, et al.
Publicat: (2002)

Identification of CDCP1 as a hypoxia-inducible factor 2 (HIF-2 ) target gene that is associated with survival in clear cell renal cell carcinoma patients
per: Emerling, B. M., et al.
Publicat: (2013)

Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
per: Giatromanolaki, A, et al.
Publicat: (2006)

VHL deficiency drives enhancer activation of oncogenes in clear cell renal cell carcinoma
per: Yao, X, et al.
Publicat: (2017)

Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients
per: Armesto, M, et al.
Publicat: (2024)

Hypoxia and angiogenesis in rheumatoid arthritis.
per: Taylor, P, et al.
Publicat: (2005)

Angiogenesis: escape from hypoxia.
per: Coleman, M, et al.
Publicat: (2009)

Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma
per: Purshouse, K, et al.
Publicat: (2019)

Renal cell carcinoma with retro-aortic renal vein thrombus: a case series.
per: Marsh, H, et al.
Publicat: (2010)

WHO/ISUP grading of clear cell renal cell carcinoma and papillary renal cell carcinoma; validation of grading on the digital pathology platform and perspectives on reproducibility of grade
per: Browning, L, et al.
Publicat: (2021)

Partial nephrectomy for renal cell carcinoma in single kidneys
per: Henderson, A, et al.
Publicat: (2008)

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
per: Jubb, A, et al.
Publicat: (2010)

Automated uro-oncology data collection: the Cancer Research Uro-Oncology Database.
per: Charlesworth, P, et al.
Publicat: (2010)

Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts.
per: Biswas, S, et al.
Publicat: (2010)

Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma.
per: Fairfax, B, et al.
Publicat: (2012)

miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
per: McCormick, R, et al.
Publicat: (2013)

Regulation of angiogenesis by hypoxia: role of the HIF system.
per: Pugh, C, et al.
Publicat: (2003)

MiR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis
per: McCormick, R, et al.
Publicat: (2013)

In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
per: Abu-Jamous, B, et al.
Publicat: (2017)

An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib
per: Pwint, T, et al.
Publicat: (2011)

An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib.
per: Pwint, T, et al.
Publicat: (2011)

Mapping hypoxia in renal carcinoma with oxygen-enhanced MRI: comparison with intrinsic susceptibility MRI and pathology
per: Little, RA, et al.
Publicat: (2018)

Angiogenesis in primary lung cancer and lung secondaries.
per: Pezzella, F, et al.
Publicat: (1996)

Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx Renal
per: Mitchell, TJ, et al.
Publicat: (2018)

Angiogenesis in endocrine tumors.
per: Turner, H, et al.
Publicat: (2003)

Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival.
per: Campo, L, et al.
Publicat: (2005)

Thyrotoxic goiter and asymptomatic thyroid nodule as an initial presentation of clear cell renal cell carcinoma: a report of two cases
per: Mohd Ghani @ Mamat, Khairul Asri, et al.
Publicat: (2019)

Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
per: Ng, Keng Lim, et al.
Publicat: (2018)